Associated tags: MRI, University of Texas System, Caregiver, Master of Science, Protein, Health, COVID, Mexican Americans, Infection, University, Workforce, African Americans, Cognition, Plasma, Nursing, Deficit spending, Magnetic resonance imaging, Neurodegenerative disease, Antibody, Genetics, Biomarker, Data collection, Neurology, Biology, School, Research, MD, Doctor of Philosophy, COVID-19, NIA, Participation, Cognitive deficit, Pharmaceutical industry
Locations: TEXAS, BIGGS, SAN ANTONIO, NEW YORK, CHILE, LAREDO, NIGERIA, BOLIVIA, ARGENTINA
Retrieved on:
Thursday, December 21, 2023
MRI,
Risk,
University of Texas System,
Caregiver,
Master of Science,
Protein,
Health,
COVID,
Mexican Americans,
Infection,
University,
Workforce,
African Americans,
Cognition,
Plasma,
Nursing,
Deficit spending,
Magnetic resonance imaging,
Neurodegenerative disease,
Antibody,
Genetics,
Biomarker,
Data collection,
Neurology,
Biology,
School,
Research,
MD,
Doctor of Philosophy,
COVID-19,
NIA,
Participation,
Cognitive deficit,
Pharmaceutical industry SAN ANTONIO, Dec. 21, 2023 /PRNewswire-PRWeb/ -- COVID-19's long-term effects on cognition in older adults will be studied for five years thanks to a $32 million federal grant awarded to The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio).
Key Points:
- The U.S. National Institute on Aging (NIA) awarded $32 million to The University of Texas Health Science Center at San Antonio to coordinate the study.
- Researchers will focus on the recruitment and analysis of populations most severely affected by long COVID.
- "Cognitive impairment is seen in some adults over 60 who are experiencing long COVID, and this impairment appears to be progressive."
- "Cognitive impairment is seen in some adults over 60 who are experiencing long COVID, and this impairment appears to be progressive.